Medical News

RSS

Why are Chlamydia and HPV major public health problems?

Chlamydia trachomatis is a bacterium that is one of the most common sexually transmitted infections in Europe. Rates in sexually active young people are commonly between 5% and 10%. The number of diagnosed cases is increasing in many European countries, in part due to increased testing and the use of more sensitive tests.

22 Feb 2011

New Harris Poll suggests that many doctors dont help obese patients to lose weight

A new Harris Poll suggests that many doctors are doing little or nothing to help their overweight patients to lose weight.

22 Feb 2011

Macrogen announces formation of Axeq Technologies in the US, Europe and Asia

Macrogen, Inc announces the formation of Axeq Technologies, a US-based division with operations and offices in the US, Europe and Asia. "Axeq" is a premium brand representing a whole new experience and industry-leading standards in DNA sequencing service.

22 Feb 2011

Tips for treating loose tooth

Pulling a tooth is a rite of passage for children as they shed their baby teeth for an adult set. But parents often ask: What are the safest and most painless ways to pull a loose tooth?

22 Feb 2011

Henry Schein fourth quarter net sales increase 15.1% to $7.5 billion

Henry Schein, Inc., the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended December 25, 2010.

22 Feb 2011

CTS unveils world's first adjustable Patient Passport Express kiosks at HIMSS conference

Connected Technology Solutions has unveiled the world's first adjustable self-service healthcare kiosk in Booth 3184 at the 2011 HIMSS Conference & Exhibition, the annual tradeshow for healthcare IT professionals in Orlando, Florida.

22 Feb 2011

Noninvasive test to evaluate risk of ASD in infants

A computational physicist and a cognitive neuroscientist at Children's Hospital Boston have come up with the beginnings of a noninvasive test to evaluate an infant's autism risk.

22 Feb 2011

China Cord Blood announces formation of Zhejiang Lukou Biotechnology

China Cord Blood Corporation, the first and largest cord blood banking operator in China, today announced the formation of Zhejiang Lukou Biotechnology Co., Ltd., an indirect non-wholly owned subsidiary with the Zhejiang Provincial Blood Center, pursuant to the Company's framework agreement announced in September 2010.

22 Feb 2011

NHC announces net income of $3.22 per share for year ended Dec. 31, 2010

National HealthCare Corporation, one of the nation's oldest long-term health care companies, today announced net income available to common shareholders of $44,022,000 or $3.22 per share basic for the year ended Dec. 31, 2010, compared to $31,376,000 or $2.31 per share basic for the year ended Dec. 31, 2009, an increase of 40.3%.

22 Feb 2011

Epilepsy patients with low SES more likely to have poor quality of life

A newly published report reveals patients with epilepsy and low socioeconomic status are more likely to have uncontrolled seizures, drug-related side effects, and a lower overall quality of life.

22 Feb 2011

New community partnership launched to provide free vision care services for Akron-area children

Davis Vision, Prevent Blindness Ohio and Summa Hospital's Ophthalmology Department have launched an ongoing community partnership to provide needy Akron-area children with free vision care services.

22 Feb 2011

Vical extends relationship with U.S. NMRC for emerging disease vaccine platform

Vical Incorporated announced today that the company has extended its relationship with the U.S. Naval Medical Research Center to develop its platform technology for the rapid development and production of vaccines against emerging infectious diseases.

22 Feb 2011

SEIU's allegation concerning malnutrition rates is baseless, say Prime Healthcare hospitals

The February 19, 2011 article written by reporters from California Watch repeats SEIU's allegation that Prime Healthcare hospitals use a diagnosis of malnutrition to increase reimbursement.

22 Feb 2011

FDA approves OraSure's rapid antibody test to detect HCV

OraSure Technologies, Inc. announced today that its OraQuick HCV Rapid Antibody Test has now been approved by the U.S. Food and Drug Administration for use in detecting HCV antibodies with a fingerstick whole blood sample.

22 Feb 2011

Scientists believe plant extracts may have medical benefits to treat herpes

For centuries tansy has been used as a folk remedy, but now scientists from Britain and Spain believe the plant may have medical benefits after all, as a treatment for herpes. The team's findings, published in Phytotherapy Research, are the result of joint work between two teams to established scientific evidence for traditional medicines.

22 Feb 2011

FDA refuses Delcath's chemosaturation delivery system NDA filing

Delcath Systems, Inc. announced today that the Company has received a "refusal to file" letter from the U.S. Food & Drug Administration for the New Drug Application for its proprietary chemosaturation system used in the treatment of patients with metastatic melanoma in the liver through the percutaneous intra-arterial administration of melphalan hydrochloride.

22 Feb 2011

Xerox helps healthcare clients with technology and consulting services to improve quality of care

A growing number of healthcare organizations are turning to Xerox Corporation for technology and consulting services in support of Electronic Health Records. In the past year, more than 50 clients hired Xerox to advise them on everything from securing meaningful use funding to building Health Information Exchanges.

22 Feb 2011

Mutated cancer pathway studies identify therapeutic targets for congenital heart disease

Cross-disciplinary teams of scientists studying genetic pathways that are mutated in many forms of cancer, but which also cause certain forms of congenital heart disease - including hypertrophic cardiomyopathy, a thickening of the heart muscle that is the leading cause of sudden death in children and young adults -, have introduced these mutations into mice and successfully treated HCM in the lab.

22 Feb 2011

Pieris: New interim PRS-050 Phase I data against cancer to be presented at Tri-Conference in California

Pieris AG announced today the upcoming presentation of new preclinical and interim Phase I clinical trial data for its PRS-050 Anticalin(r) program, currently under evaluation for the treatment of cancer.

22 Feb 2011

MedTrust, Avantra collaborate to develop molecular diagnostic assay for cancer care

MedTrust Online and Avantra Biosciences announced today a novel collaboration to involve clinicians in the earliest stages of molecular diagnostic assay development for Avantra Biosciences' revolutionary QPDx multiplex immunoassay system.

22 Feb 2011

Medical News

Why are Chlamydia and HPV major public health problems?

New Harris Poll suggests that many doctors dont help obese patients to lose weight

Macrogen announces formation of Axeq Technologies in the US, Europe and Asia

Tips for treating loose tooth

Henry Schein fourth quarter net sales increase 15.1% to $7.5 billion

CTS unveils world's first adjustable Patient Passport Express kiosks at HIMSS conference

Noninvasive test to evaluate risk of ASD in infants

China Cord Blood announces formation of Zhejiang Lukou Biotechnology

NHC announces net income of $3.22 per share for year ended Dec. 31, 2010

Epilepsy patients with low SES more likely to have poor quality of life

New community partnership launched to provide free vision care services for Akron-area children

Vical extends relationship with U.S. NMRC for emerging disease vaccine platform

SEIU's allegation concerning malnutrition rates is baseless, say Prime Healthcare hospitals

FDA approves OraSure's rapid antibody test to detect HCV

Scientists believe plant extracts may have medical benefits to treat herpes

FDA refuses Delcath's chemosaturation delivery system NDA filing

Xerox helps healthcare clients with technology and consulting services to improve quality of care

Mutated cancer pathway studies identify therapeutic targets for congenital heart disease

Pieris: New interim PRS-050 Phase I data against cancer to be presented at Tri-Conference in California

MedTrust, Avantra collaborate to develop molecular diagnostic assay for cancer care

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News